Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Scotty Rose

Physician Assistant Beckley, WV Physician Assistant

NPI 1780627885 CMS profile 11106257

101 S Eisenhower Dr, Beckley, WV 25801

Open in the dashboard

General payments

$6,296

407 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Scotty Rose of Beckley, WV is reported in the CMS Open Payments database as having received $6,296 across 407 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,593 89
2024 General $1,017 55
2023 General $1,296 75
2022 General $1,144 77
2021 General $1,245 111

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scotty Rose
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Scotty Rose were reported at $1,593. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Scotty Rose Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $1,245 $132 $37–$438 $132
2022 $1,144 $155 $48–$522 $149
2023 $1,296 $167 $52–$557 $160
2024 $1,017 $178 $55–$600 $164
2025 $1,593 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Teva Pharmaceuticals USA, Inc. $1,467 84 payments
  2. AbbVie, Inc. $1,153 95 payments
  3. Janssen Pharmaceuticals, Inc $728 41 payments
  4. Lundbeck LLC $633 35 payments
  5. ITI, Inc. $541 39 payments
  6. Alkermes, Inc. $533 33 payments
  7. Sunovion Pharmaceuticals Inc. $449 35 payments
  8. Otsuka America Pharmaceutical, Inc. $231 13 payments
  9. Vanda Pharmaceuticals Inc. $169 7 payments
  10. E.R. Squibb & Sons, L.L.C. $156 12 payments
  11. Other $236 13 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $6,169 405 payments
  2. Education $126 2 payments
Products named General payments · program years 2021–2025
  1. VRAYLAR $873 76 payments
  2. Austedo XR $755 41 payments
  3. INVEGA SUSTENNA $688 39 payments
  4. AUSTEDO $577 39 payments
  5. ABILIFY MAINTENA $545 30 payments
  6. LYBALVI $522 32 payments
  7. CAPLYTA $513 38 payments
  8. ARISTADA Cns $511 31 payments
  9. ARISTADA Cns $511 31 payments
  10. ARISTADA Cns $511 31 payments
  11. Other $3,154 199 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

407 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record